Cardiac abnormalities in acute organophosphate poisoning
Authors:
- 1 March 2009
- journal article
- research article
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 47 (3) , 230-235
Abstract
Background. Potentially lethal cardiac complications can occur in patients with acute organophosphate poisoning (OPP) and may be overlooked. Patients and Methods. Thirty-six patients with acute OPP were studied. Clinical features and the nature of compound involved were recorded. The QT interval was plotted against heart rate to determine the risk for Torsades de Pointes using the Fossa nomogram. Echocardiography was undertaken in 29 patients. Twenty-four-hour Holter monitoring was performed on day 1 in five patients. Thirteen died. Necropsy was performed and hearts were studied both grossly and microscopically. Results. Gross examination of the heart in 13 cases revealed cardiac discoloration or blotchiness in 12, patchy pericarditis in six, auricular thrombus in six, right ventricular hypertrophy in four, and dilatation in three. On histopathology, all 13 cases had myocardial interstitial edema and vascular congestion, eight had patchy interstitial inflammation, two had patchy myocarditis, and six had a mural thrombus. Sinus tachycardia was the most common electrocardiographic abnormality. The others were corrected QT interval prolongation, ST–T changes, U waves, and ventricular premature contractions. Echocardiography in 29 patients showed minor abnormalities in 10. On Holter monitoring, episodic tachycardia and ST–T changes were observed in four, QT prolongation in three, and episodic bradycardia in two. Conclusions. Patchy myocardial involvement as a result of direct cardiac toxicity could be one of the factors responsible for serious cardiac complications. As myocardial involvement is patchy, it may not be manifest clinically or on echocardiography. Continuous cardiac monitoring should be undertaken to detect dynamic cardiac changes.Keywords
This publication has 18 references indexed in Scilit:
- Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogramQJM: An International Journal of Medicine, 2007
- Guidelines for Treating Cardiac Manifestations of Organophosphates Poisoning with Special Emphasis on Long QT and Torsades De PointesCritical Reviews in Toxicology, 2007
- Evaluation of Several Clinical Scoring Tools in Organophosphate Poisoned PatientsClinical Toxicology, 2006
- Dynamic Beat-to-Beat Modeling of the QT-RR Interval Relationship: Analysis of QT Prolongation during Alterations of Autonomic State versus Human Ether a-go-go-Related Gene InhibitionThe Journal of Pharmacology and Experimental Therapeutics, 2005
- ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary articleJACC, 2003
- Organophosphorus poisoning and anaesthesiaAnaesthesia, 1999
- Cardiac manifestations of acute carbamate and organophosphate poisoning.Heart, 1997
- QTc prolongation indicates a poor prognosis in patients with organophosphate poisoningThe American Journal of Emergency Medicine, 1996
- Myocarditis: The Dallas criteriaHuman Pathology, 1987
- Q-T prolongation and polymorphous (“torsade de pointes”) ventricular arrhythmias associated with organophosphorus insecticide poisoningThe American Journal of Cardiology, 1982